Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,279,131
-
Share change
-
+34,212
-
Total reported value
-
$21,526,740
-
Put/Call ratio
-
415%
-
Price per share
-
$5.03
-
Number of holders
-
60
-
Value change
-
-$4,779,569
-
Number of buys
-
30
-
Number of sells
-
27
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q3 2014
As of 30 Sep 2014,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,279,131 shares.
The largest 10 holders included
Catalyst Capital Advisors LLC, VANGUARD GROUP INC, Cormorant Asset Management, LLC, BlackRock Fund Advisors, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, State Street Corp, BlackRock Institutional Trust Company, N.A., Neuberger Berman Group LLC, and Benchmark Capital Advisors.
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.